Dividend Increase – Digital Realty Trust Inc. (DLR)

Yesterday the Board of Directors of Digital Realty Trust Inc. announced a quarterly dividend increase of from $0.83 to $0.85 per share that’s payable March 31, 2015 to holders of record March 13, 2015. This represents a 2.4% increase to regular quarterly dividends. With current price $65.60 (today's open), this raise brings their dividend yield to 5.18%. 

Since I own 120 shares, this will increase my portfolio's projected annual net dividend income by $7.15.

That increase rises my YOC to 7.12%.

Click here to see my portfolio holdings.

You can follow the development of my dividends here.

Dividend Increase – Toronto-Dominion Bank (TD)

Today the Board of Directors of Toronto-Dominion Bank announced a quarterly dividend increase of from CA$0.47 to CA$0.51 per share that’s payable April 30, 2015 to holders of record April 7, 2015. This represents a 8.51 % increase to regular quarterly dividends. With current price CA$54.70 (today's open), this raise brings their dividend yield to 3.73%. 

Since I own 80 shares, this will increase my portfolio's projected annual net dividend income by CA$9.54.

That increase rises my YOC to 3.75%.

Click here to see my portfolio holdings.

You can follow the development of my dividends here.

Dividend Increase – Royal Bank of Canada (RY)

Today the Board of Directors of Royal Bank of Canada announced a quarterly dividend increase of from CA$0.75 to CA$0.77 per share that’s payable May 22, 2015 to holders of record April 23, 2015. This represents a 8.45 % increase over the first quarter 2014 dividend of CA$0.71 per share and a 2.67 % increase over for the third quarter 2014 of CA$0.75 per share. With current price CA$75.05 (yesterday's close), this raise brings their dividend yield to 4.10%. 

Since I own 55 shares, this will increase my portfolio's projected annual net dividend income by CA$3.28.

That increase rises my YOC to 3.94%.

Click here to see my portfolio holdings.

You can follow the development of my dividends here.

Week in Review 8/15

Welcome and thanks for reading! In this review, I will gather together important and interesting news and events over the last week related to my portfolio holdings. In my week review, I put also together some interesting articles from other websites that caught my attention during the past week.

Dividend Increase – The Coca-Cola Company (KO)

Yesterday the Board of Directors of The Coca-Cola Company announced a quarterly dividend increase of from $0.305 to $0.33 per share that’s payable April 1, 2015 to holders of record March 16, 2015. This represents a 8.2% increase to regular quarterly dividends. With current price $42.11 (yesterday's close), this raise brings their dividend yield to 3.13%. 

Since I own 150 shares, this will increase my portfolio's projected annual net dividend income by $11.18.

That increase rises my YOC to 3.53%.

Click here to see my portfolio holdings.

You can follow the development of my dividends here.

Recent Buy - Baxter International Inc. (BAX)

18th February 2015 I Bought 30 shares of BAX at $68.32 per share plus commission.

Baxter International Inc. develops, manufactures, and markets products for people with hemophilia, immune disorders, infectious diseases, kidney diseases, trauma, and other chronic and acute medical conditions. Its BioScience segment processes recombinant and plasma-based proteins to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies, alpha-1 antitrypsin deficiency, burns and shock, and other chronic and acute blood-related conditions; biosurgery products; and certain vaccines. The companys Medical Products segment manufactures intravenous (IV) solutions and administration sets, premixed drugs and drug-reconstitution systems, pre-filled vials and syringes for injectable drugs, IV nutrition products, infusion pumps, and inhalation anesthetics; products and services related to pharmacy compounding, drug formulation, and packaging technologies; and technologies and therapies for peritoneal dialysis, in-center and home hemodialysis, and continuous renal replacement therapy.

Week in Review 7/15

Welcome and thanks for reading! In this review, I will gather together important and interesting news and events over the last week related to my portfolio holdings. In my week review, I put also together some interesting articles from other websites that caught my attention during the past week.

Recent Buy - TELUS Corporation (NYSE:TU, TSE:T)

February 9, 2015 I made two acquisitions. In addition to the purchase of JNJ, I also bought 50 shares of TU at $33.90 per share plus commission.

TELUS Corporation provides a range of telecommunications services and products in Canada. The company operates through two segments, Wireless and Wireline. Its telecommunications services and products include wireless and wireline voice and data; data services, such as Internet protocol; television; hosting, managed information technology, and cloud-based services; and healthcare solutions. The company also offers cellular and other wireless services, as well as sells wireless handsets, parts and accessories, and communications equipment. In addition, it holds radio communication spectrum licenses for various wireless services and applications; and operates a video-on-demand programming service. As of May 6, 2014, TELUS Corporation had approximately 13.3 million customer connections, including 7.8 million wireless subscribers, 3.3 million wireline network access lines, 1.4 million Internet subscribers, and 815,000 TELUS TV customers. The company was formerly known as TELUS Communications Inc. and changed its name to TELUS Corporation in February 2005. TELUS Corporation was founded in 1993 and is based in Vancouver, Canada. (Yahoo Finance)

Recent Buy - Johnson & Johnson (JNJ)

9th February 2015 I Bought 20 shares of JNJ at $99.90 per share plus commission.

Johnson & Johnson, together with its subsidiaries, is engaged in the research and development, manufacture, and sale of various products in the health care field worldwide. The company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. The Consumer segment offers a range of products used in the baby care, skin care, oral care, wound care, and womens health fields, as well as nutritionals, over-the-counter pharmaceutical products, and wellness and prevention platforms under the JOHNSONS, AVEENO, CLEAN & CLEAR, DABAO, JOHNSONS Adult, LUBRIDERM, NEUTROGENA, RoC, VENDÔME, LISTERINE, BAND-AID, NEOSPORIN, STAYFREE, CAREFREE, o.b. tampon, SPLENDA, TYLENOL, SUDAFED, ZYRTEC, MOTRIN IB, and PEPCID brand names. 

Week in Review 6/15

Welcome and thanks for reading! In this review, I will gather together important and interesting news and events over the last week related to my portfolio holdings. In my week review, I put also together some interesting articles from other websites that caught my attention during the past week.

Dividend Income - January 2015

In January 2015 my portfolio dividend income was as follows:

Quarterly dividends received from:

PepsiCo Inc. (PEP) - €55.68 ($65.50)

Altria Group Inc. (MO) - €76.37 ($91.00) 

Philip Morris International Inc. (PM) - €72.25 ($85.00)

Digital Realty Trust Inc. (DLR) - €83.77 ($99.60)

Kraft Foods Group Inc. (KRFT) - €46.47 ($55.00)
General Electric Co. (GE) - €36.84 ($41.40)

Bank of Nova Scotia (BNS.TO) - €46.20 ($56.80) (CA$66.00)

Dividend Increase – UPM-Kymmene Corporation

As the frontrunner of the new forest industry UPM leads the integration of bio and forest industries into a new, sustainable and innovation-driven future. We create value from renewable and recyclable materials.

UPM’s structure consists of the following business areas: UPM Biorefining, UPM Energy, UPM Raflatac, UPM Paper Asia, UPM Paper ENA (Europe and North America) and UPM Plywood.

In 2013, UPM's sales exceeded € 10 billion. UPM is present in 65 countries and has production plants in 14 countries. The company employs approximately 21,000 people worldwide. UPM shares are listed on the NASDAQ OMX Helsinki stock exchange. (upm.com)

 

Today UPM Board of Directors has approved a new dividend policy according to which the company aims to pay an attractive dividend, 30-40% of the company’s annual operating cash flow per share.

Week in Review 5/15

Welcome and thanks for reading! In this review, I will gather together important and interesting news and events over the last week related to my portfolio holdings. In my week review, I put also together some interesting articles from other websites that caught my attention during the past week.